ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
21.56
+0.19 (0.87%)
Nov 21, 2024, 1:24 PM EST - Market open
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $5.10 billion as of November 21, 2024. Its market cap has increased by 513.98% in one year.
Market Cap
5.10B
Enterprise Value
5.08B
1-Year Change
513.98%
Ranking
Category
Stock Price
$21.56
Market Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $5.10B, an increase of 10,050.18%. That is a compound annual growth rate of 51.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 5.05B | 394.59% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avidity Biosciences | 4.93B |
| PROCEPT BioRobotics | 4.92B |
| Stevanato Group | 4.85B |
| Arcellx | 4.77B |
| Select Medical Holdings | 4.72B |
| Biohaven | 4.59B |
| Integer Holdings | 4.51B |
| Axsome Therapeutics | 4.48B |